title: Revisions to Exceptions Applicable to Certain Human Cells,   Tissues, and Cellular and Tissue-Based Products. Final rule.
abstract: : The Food and Drug Administration (FDA or Agency or we) is issuing this final rule to amend certain regulations regarding donor eligibility, including the screening and testing of donors of particular human cells, tissues, and cellular and tissue-based products (HCT/Ps), and related labeling. This final rule is in response to our enhanced understanding in this area and in response to comments from stakeholders regarding the importance of embryos to individuals and couples seeking access to donated embryos.
mesh_terms: D001688:Biological Products / Q000592:standards*; D046148:Donor Selection / Q000331:legislation & jurisprudence* / Q000592:standards; D004608:Eligibility Determination / Q000331:legislation & jurisprudence*; D004622:Embryo, Mammalian; D005854:Germ Cells; D006801:Humans; D011356:Product Labeling / Q000331:legislation & jurisprudence / Q000592:standards; D014019:Tissue Donors / Q000331:legislation & jurisprudence*; D014481:United States
chemical_list: D001688:Biological Products